Cytosorbents Corp. (CTSO) is a publicly traded Healthcare sector company. As of May 21, 2026, CTSO trades at $0.47 with a market cap of $30.08M and a P/E ratio of -2.41. CTSO moved +0.00% today. Year to date, CTSO is -29.44%; over the trailing twelve months it is -44.08%. Its 52-week range spans $0.45 to $1.61. Analyst consensus is neutral with an average price target of $0.75. Rallies surfaces CTSO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CTSO financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CTSO recently traded at $0.47. Market cap is $30.08M. P/E ratio is -2.41. Revenue is $37.20M.
| Metric | Value |
|---|---|
| Price | $0.47 |
| Market Cap | $30.08M |
| P/E Ratio | -2.41 |
| EPS | $-0.19 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.61 |
| 52-Week Low | $0.45 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $37.20M |
| Net Income | $-11.85M |
| Gross Margin | 71.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $37.06M | $-8.20M | $-0.13 |
| 2024 | $35.59M | $-20.72M | $-0.38 |
| 2023 | $36.35M | $-28.51M | $-0.64 |
| 2022 | $34.69M | $-32.81M | $-0.75 |
1 analysts cover CTSO: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.75.